Perspective: The COVID-19 Pandemic: Closing Borders, Opening Doors, and Breaking Ground on the Potential for Clinical Trial Access in Developing Countries Like Trinidad and Tobago

• Kellie Alleyne-Mike,
• John Glod,
• Erissa Cuffie,
• Rajiv Kissoon,
• Bernard Bedaysie,
• Pearse Sylvester,
• Matthew Boron,
• J. Michelle Brockman,
• Nancy Moore,
• Alice P. Chen,
• Elad Sharon

Affiliations

Kellie Alleyne-Mike

Cancer Centre of Trinidad and Tobago, St James Medical Complex, St James, Trinidad and Tobago

John Glod

Center for Cancer Research, National Cancer Institute, Bethesda, MD

Erissa Cuffie

Cancer Centre of Trinidad and Tobago, St James Medical Complex, St James, Trinidad and Tobago

Rajiv Kissoon

Cancer Centre of Trinidad and Tobago, St James Medical Complex, St James, Trinidad and Tobago

Bernard Bedaysie

Radiology Department, Port-of-Spain General Hospital, Port-of-Spain, Trinidad and Tobago

Pearse Sylvester

Cancer Centre of Trinidad and Tobago, St James Medical Complex, St James, Trinidad and Tobago

Matthew Boron

Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD

J. Michelle Brockman

Genentech, a Member of the Roche Group, San Francisco, CA

Nancy Moore

Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD

Alice P. Chen

Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD

Elad Sharon

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA